ResMed, Inc. (RMD) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.00 --0%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
